Volume: 43 Issue: Supplementary 1
Year: 2023, Page: 225-229, Doi: https://doi.org/10.51248/.v43i1.2432
Introduction and Aim: Diabetes mellitus is a complex disease that is a major global health problem. It is defined as a chronic metabolic disease characterized by high blood glucose levels. Diabetes risk has been linked to genetic variations within mitochondrial DNA. The current study sought to identify and compare genetic variation (mutations) in ATPase genes in diabetic patients and healthy individuals.
Materials and Methods: This study included 100 individuals (50 T2DM patients and 50 healthy volunteers). Peripheral blood samples were collected from each individual and DNA extracted. The mitochondrial mtATPase genes were amplified using specific primers by polymerase chain reaction. The amplified products were sequenced, and the sequences obtained analyzed for nucleotide changes.
Results: The ATPase gene sequence analysis revealed nine nucleotide changes, three of which (A9039G, G9092A, and G9100T) are classified as polymorphisms in the human mitochondrial genome database. Furthermore, we presented the first description of mutations in ATPase genes such as (A8586G, C8637T, G8813A, A8953G, C8981T and T9024G). The A9039G mutation changed the amino acid isoleucine to glycine, the G9100T mutation changed the amino acid serine to isoleucine, and the C8981G mutation changed the amino acid threonine to isoleucine. Most patients were found to predict haplogroup H2a (H2a2), in addition to having H1c (H1c3) and L1c(L1c2). The presence of genetic variations in mtATPase genes may be an inheritable risk factor for type 2 diabetes mellitus pathogenesis.
Conclusion: Variants in ATPase mitochondrial genes may be one of the risk factors associated with type 2 diabetes. Hence, documenting these mutations is clinically important in the possibility of diagnosing diabetes, as well as the likelihood that these mutations could be pathogenic
Keywords: Type 2 diabetes mellitus; ATPase genes; mtDNA; haplogroup
1. Spira, A., Gowrishankar, M., Halperin, M. Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus. American Journal of Kidney Diseases, 1997; 30(6):829-835.
2. Chauhan, N. S., Dixit, V. K., Antihyperglycemic activity of the ethanolic extract of Curculigo orchioides Gaertn. Phcog Mag, 2007;3(12):237.
3. Nettina, S. M., Msn, A.B., Nettina, S. M. Lippincott manual of nursing practice. Lippincott Williams & Wilkins, 2013.
4. Rajagopal, K., Sasikala, K. Antihyperglycemic and antihyperlipidemic effects of Nymphaea stellata in alloxan-induced diabetic rats. Singapore Medical Journal, 2008;49(2):137.
5. Pesta, D., Roden, M. The Janus head of oxidative stress in metabolic diseases and during physical exercise. Current diabetes reports. 2017;17(6):41.
6. Brown, D.I., Griendling, K.K. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circulation research, 2015;116(3):531-549.
7. Charoute, H., Kefi, R., Bounaceur, S., Benrahma, H., Reguig, A., Kandil, M., et al., Novel variants of mitochondrial DNA associated with Type 2 diabetes mellitus in Moroccan population. Mitochondrial DNA Part A. 2018;29(1):9-13.
8. Al-Hussona A. J., Ahmed F.A. Mitochondrial DNA Variants from Atp8, Atp6 Genes in Patients’ Cardiac Valves. World J. Pharmaceutical Res, 2019;8(9):1584-1592.
9. Fakhry, S.S., Hammed, Z.N., Bakir, W.A. E., AL-Rubaii, B.A.L. Identification of methicillin-resistant strains of Staphylococcus aureus isolated from humans and food sources by use mecA 1 and mecA 2 genes in Pulsed-field gel electrophoresis technique, 2022, 7(2):44. DOI. 10.21931/RB/2022.07.02.44.
10. Jiad, A.L., Ismael, M.K., Salih, T.A., Malik, S. N., Al-Rubaii, B.A.L. Genotyping and evaluation of interleukin-10 and soluble HLA-G in abortion due to toxoplasmosis and HSV-2 infections. Annals of Parasitology. 2022, 68(2):385-390.
11. Ali, S. M., Lafta, B.A., Al-Shammary, A.M., Salih, H.S. In vivo oncolytic activity of non-virulent Newcastle disease virus Iraqi strain against mouse mammary adenocarcinoma. AIP Conference Proceedings, 2021, 2372, 030010.
12. Awadh, H.A., Hammed, Z.N., Hamzah, S.S., Saleh, T.H., Al-Rubaii, B.A.L. Molecular identification of intracellular survival related Brucella melitensis virulence factors. Biomedicine (India), 2022, 42(4):761-765.
13. Hashim, S.T., Fakhry, S.S., Rasoul, L.M., Saleh, T.H., Alrubaii, B.A.L. Genotyping toxins of Clostridium perfringens strains of rabbit and other animal origins. Tropical Journal of Natural Product Research. 2021; 5(4): 613-616.
14. Ahmed, A.A., Khaleel, K.J., Fadhel, A.A., Al-Rubaii, B.A.L. Chronic Myeloid Leukemia: A retrospective study of clinical and pathological features. Bionatura, 2022; 7(3): 41. DOI. 10.21931/RB/2022.07.03.41
15. Lorenz, R., Bernhart, S.H., Siederdissen, C.H., Tafer, H., Flamm, C., Stadler, P.F., et al., ViennaRNA Package 2.0. Algorithms for Molecular Biology, 2011;6(1):1-4.
16. Ashcroft, F.M. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest. 2005; 115(8):2047-2058.
17. Hanna, M.G., Nelson, I., Sweeney, M.G., Cooper, J.M., Watkins, P.J., Morgan, J.A., et al., encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. American Journal of Human Genetics,1995;56(5):1026-1033.
18. Martin, I., Pape, E., Pavlić, I. Metelko, Ž., Metelko, Z., Kusec, R., et al., Pilot study of mitochondrial DNA point mutation A3243G in a sample of Croatian patients having type 2 diabetes mellitus associated with maternal inheritance. Acta Diabetologica, 2004;41(4):179-184.
19. Jiang, W., Li, R., Zhang, Y., Wang, P. Mitochondrial DNA mutations associated with type 2 diabetes mellitus in Chinese Uyghur population. Scientific Reports, 2017;7(1):1-9.
20. Brown, M.D., Zhadanov, S., Allen, J.C., Hosseini, S., Newman, N. Novel mtDNA mutations and oxidative phosphorylation dysfunction in Russian LHON families. Human Genetics, 2001;109(1):33-39.
21. Shinde, S., Kumar, P., Mishra, K., Patil, N. Defect in mitochondrial functions in damaged human mitral valve. Indian Journal of Clinical Biochemistry, 2006;21(2):156-160.
22. Kwak, S.H., Park, K.S. Role of mitochondrial DNA variation in the pathogenesis of diabetes mellitus. Front Biosci (Landmark Ed), 2016;21(21):1151-1167.
23. Park, K.S., Chan, J.C., Chuang, L.M., Suzuki, S., Araki, E., Nanjo, K., et al., A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia, 2008;51(4):602-608.
24. Chinnery, P. F., Mowbray, C., Patel, S.K., Elson, J.L. Mitochondrial DNA haplogroups and type 2 diabetes: a study of 897 cases and 1010 controls. Journal of medical genetics, 2007;44(6): e80- e83.
Ali Jumaah Alhussona, Ali Habeeb Al-Musawi, Hayder Hussein Jalood, Sawsan S. Hamzah. A study of ATPase gene variants of mitochondrial DNA in patients with Type 2 diabetes mellitus. Biomedicine: 2023; 43(1) Supplementary issue: 225-229